Evaluation of Flow Diverter Technology Device for Intracranial Aneurysm (SHIELD)

Recruiting now · Not applicable

Conditions studied: Aneurysm

In brief

The Jacobs Institute is participating in a study designed to collect prospective clinical evidence to evaluate the approved use of the Pipeline™ Flex Embolization Device with Shield Technology™ for the endovascular treatment of adults (22 years of age or older) with wide-necked intracranial aneurysms

Key facts

Study ID

NCT06793059

Run by

Jacobs institute

People needed

10

Starts

2025-01-01

Expected to finish

2027-01-01

Last updated by the study team

2026-03-10

Who can join

Age: 22 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adults (22 years of age or older) with large or giant wide-necked intracranial aneurysms (IAs) in the internal carotid artery from the petrous to the superior hypophyseal segments.

You may not qualify if…

• Exclusion Criteria:
• Cannot provide consent or legally authorized representative not available to provide consent Criteria:

Where it is running

• Jacobs Institute — Buffalo, New York, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.